If you look at what was stated in the update of 15th December:
The TGA have completed a preliminary review and have requested that AnteoTech supply additional information and clarification in support of its submission.The information requested relates to the performance of AnteoTech’s RDT in relation to the detection of SARS-CoV-2 variants. In addition, the TGA has requested that AnteoTech provide plans for the monitoring of the emergence of new strains of SARS-CoV-2 and performance testing of the RDT against these strains, as well as other technical and performance elements.AnteoTech is working with the TGA to provide the information as quickly as possible.The Company will provide further updates as our submission progresses.
This is not a 5 minute exercise.
I'd be surprised if ADO was able to collate all that information within 4 weeks - the middle of January being a best case scenario for re-submission. I believe DT alluded to that in one of his press interviews in December.
ADO Price at posting:
28.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)